Functional MRI and neural responses in a rat model of Alzheimer's disease

NeuroImage

Volumn 79, Issue , 2013, Pages 404-411

  Sanganahalli, Basavaraju G ^a,b   Herman, Peter ^a,b   Behar, Kevin L ^a,b   Blumenfeld, Hal ^a   Rothman, Douglas L ^a,b,c   Hyder, Fahmeed ^a,b,c  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yale University   (United States)

Author keywords

Aging; Cognitive dementia; Energy metabolism; Neuroimaging; Neurovascular coupling; Thalamocortical responses

Indexed keywords

AMYLOID PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED SOMATOSENSORY RESPONSE; FOREFOOT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MALE; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; THALAMUS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; RATS; RATS, LONG-EVANS; TOUCH;

EID: 84878424485     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.04.099     Document Type: Article

References (54)

1. Aanerud J., Borghammer P., Chakravarty M.M., Vang K., Rodell A.B., Jonsdottir K.Y., Moller A., Ashkanian M., Vafaee M.S., Iversen P., Johannsen P., Gjedde A. Brain energy metabolism and blood flow differences in healthy aging. J. Cereb. Blood Flow Metab. 2012, 32:1177-1187.
2. Aguilar J., Morales-Botello M.L., Foffani G. Tactile responses of hindpaw, forepaw and whisker neurons in the thalamic ventrobasal complex of anesthetized rats. Eur. J. Neurosci. 2008, 27:378-387.
3. Ances B.M., Liang C.L., Leontiev O., Perthen J.E., Fleisher A.S., Lansing A.E., Buxton R.B. Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum. Brain Mapp. 2009, 30:1120-1132.
4. Armstrong-James M., George M.J. Bilateral receptive fields of cells in rat Sm1 cortex. Exp. Brain Res. 1988, 70:155-165.
5. Barinaga M. New imaging methods provide a better view into the brain. Science 1997, 276:1974-1976.
6. Beckmann N., Schuler A., Mueggler T., Meyer E.P., Wiederhold K.H., Staufenbiel M., Krucker T. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J. Neurosci. 2003, 23:8453-8459.
7. Benedikz E., Kloskowska E., Winblad B. The rat as an animal model of Alzheimer's disease. J. Cell. Mol. Med. 2009, 13:1034-1042.
8. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., Lee J.M., Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 2011, 14:750-756.
9. Bero A.W., Bauer A.Q., Stewart F.R., White B.R., Cirrito J.R., Raichle M.E., Culver J.P., Holtzman D.M. Bidirectional relationship between functional connectivity and amyloid-beta deposition in mouse brain. J. Neurosci. 2012, 32:4334-4340.
10. Bianchi S.L., Caltagarone B.M., Laferla F.M., Eckenhoff R.G., Kelz M.B. Inhaled anesthetic potency in aged Alzheimer mice. Anesth. Analg. 2010, 110:427-430.
11. Braakman N., Matysik J., van Duinen S.G., Verbeek F., Schliebs R., de Groot H.J., Alia A. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J. Magn. Reson. Imaging 2006, 24:530-536.
12. Buckner R.L., Snyder A.Z., Sanders A.L., Raichle M.E., Morris J.C. Functional brain imaging of young, nondemented, and demented older adults. J. Cogn. Neurosci. 2000, 12(Suppl. 2):24-34.
13. 2 in Alzheimer's disease using BOLD fMRI. Neuroimage 2011, 58:579-587.
14. Chahboune H., Ment L.R., Stewart W.B., Ma X., Rothman D.L., Hyder F. Neurodevelopment of C57B/L6 mouse brain assessed by in vivo diffusion tensor imaging. NMR Biomed. 2007, 20:375-382.
15. de Leon M., Bobinski M., Convit A., Wolf O., Insausti R. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2001, 56:820-821.
16. D'Esposito M., Deouell L.Y., Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat. Rev. Neurosci. 2003, 4:863-872.
17. Fitzpatrick S.M., Rothman D. New approaches to functional neuroenergetics. J. Cogn. Neurosci. 1999, 11:467-471.
18. Fleisher A.S., Sherzai A., Taylor C., Langbaum J.B., Chen K., Buxton R.B. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage 2009, 47:1678-1690.
19. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
20. Herman P., Sanganahalli B.G., Blumenfeld H., Hyder F. Cerebral oxygen demand for short-lived and steady-state events. J. Neurochem. 2009, 109(Suppl. 1):73-79.
21. Hesselmann V., Zaro Weber O., Wedekind C., Krings T., Schulte O., Kugel H., Krug B., Klug N., Lackner K.J. Age related signal decrease in functional magnetic resonance imaging during motor stimulation in humans. Neurosci. Lett. 2001, 308:141-144.
22. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
23. Huettel S.A., Singerman J.D., McCarthy G. The effects of aging upon the hemodynamic response measured by functional MRI. Neuroimage 2001, 13:161-175.
24. Hyder F., Rothman D.L., Blamire A.M. Image reconstruction of sequentially sampled echo-planar data. Magn. Reson. Imaging 1995, 13:97-103.
25. Hyder F., Rothman D.L., Bennett M.R. Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3549-3554.
26. Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 2004, 45:583-595.
27. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
28. Jack C.R. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 2012, 263:344-361.
29. Jack C.R., Wengenack T.M., Reyes D.A., Garwood M., Curran G.L., Borowski B.J., Lin J., Preboske G.M., Holasek S.S., Adriany G., Poduslo J.F. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J. Neurosci. 2005, 25:10041-10048.
30. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
31. Johnson S.C., Saykin A.J., Baxter L.C., Flashman L.A., Santulli R.B., McAllister T.W., Mamourian A.C. The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and Alzheimer disease. Neuroimage 2000, 11:179-187.
32. Kida I., Maciejewski P.K., Hyder F. Dynamic imaging of perfusion and oxygenation by functional magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2004, 24:1369-1381.
33. Lecanu L., Greeson J., Papadopoulos V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology 2006, 76:19-33.
34. Lecanu L., Rammouz G., McCourty A., Sidahmed E.K., Greeson J., Papadopoulos V. Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer's disease. Neuroscience 2010, 165:427-435.
35. Lin A.L., Laird A.R., Fox P.T., Gao J.H. Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease. Neurol. Res. Int. 2012, 2012:907409.
36. Liu L., Orozco I.J., Planel E., Wen Y., Bretteville A., Krishnamurthy P., Wang L., Herman M., Figueroa H., Yu W.H., Arancio O., Duff K. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol. Dis. 2008, 31:46-57.
37. McGowan E., Eriksen J., Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 2006, 22:281-289.
38. Mueggler T., Sturchler-Pierrat C., Baumann D., Rausch M., Staufenbiel M., Rudin M. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J. Neurosci. 2002, 22:7218-7224.
39. Mueggler T., Baumann D., Rausch M., Staufenbiel M., Rudin M. Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease. J. Neurosci. 2003, 23:8231-8236.
40. Nordberg A., Rinne J.O., Kadir A., Langstrom B. The use of PET in Alzheimer disease. Nat. Rev. Neurol. 2010, 6:78-87.
41. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic, San Diego. 4th Ed.
42. Poduslo J.F., Wengenack T.M., Curran G.L., Wisniewski T., Sigurdsson E.M., Macura S.I., Borowski B.J., Jack C.R. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol. Dis. 2002, 11:315-329.
43. Quiroga R.Q., Nadasdy Z., Ben-Shaul Y. Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering. Neural Comput. 2004, 16:1661-1687.
44. Rombouts S.A., Goekoop R., Stam C.J., Barkhof F., Scheltens P. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage 2005, 26:1078-1085.
45. Rosengarten B., Paulsen S., Burr O., Kaps M. Neurovascular coupling in Alzheimer patients: effect of acetylcholine-esterase inhibitors. Neurobiol. Aging 2009, 30:1918-1923.
46. Sanganahalli B.G., Bailey C.J., Herman P., Hyder F. Tactile and non-tactile sensory paradigms for fMRI and neurophysiologic studies in rodents. Methods Mol. Biol. 2009, 489:213-242.
47. Sanganahalli B.G., Herman P., Blumenfeld H., Hyder F. Oxidative neuroenergetics in event-related paradigms. J. Neurosci. 2009, 29:1707-1718.
48. Small S.A., Wu E.X., Bartsch D., Perera G.M., Lacefield C.O., DeLaPaz R., Mayeux R., Stern Y., Kandel E.R. Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice. Neuron 2000, 28:653-664.
49. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12:585-601.
50. Sperling R. Potential of functional MRI as a biomarker in early Alzheimer's disease. Neurobiol. Aging 2011, 32(Suppl. 1):S37-S43.
51. Tanovic A., Alfaro V. Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia. Rev. Neurol. 2006, 42:607-616.
52. Vanhoutte G., Dewachter I., Borghgraef P., Van Leuven F., Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn. Reson. Med. 2005, 53:607-613.
53. Wengenack T.M., Reyes D.A., Curran G.L., Borowski B.J., Lin J., Preboske G.M., Holasek S.S., Gilles E.J., Chamberlain R., Marjanska M., Jack C.R., Garwood M., Poduslo J.F. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage 2011, 54:113-122.
54. Zhang D., Raichle M.E. Disease and the brain's dark energy. Nat. Rev. Neurol. 2010, 6:15-28.